Proportion of the target population who received a 3rd dose of in Europe and Northern America

Europe and Northern America: Proportion of the target population who received a 3rd dose of was 83.0% in 2024. ▲ Rising

Latest (2024)
83.0%
Change on year
unchanged
Rank
9th
of 37 groups
All-time high
84.0%
in 2019
All-time low
39.0%
in 2008
Years of data
17
2008–2024

Proportion of the target population who received a 3rd dose of in Europe and Northern America, 2008–2024

0204060802008201620242008: 392009: 432010: 562011: 582012: 592013: 602014: 612015: 612016: 682017: 762018: 812019: 842020: 812021: 822022: 832023: 832024: 83

Source: United Nations Statistics Division, SDG Global Database.

Analysis

The most recent figure for proportion of the target population who received a 3rd dose of in Europe and Northern America is 83.0%, measured in 2024.

The figure is up 36.1% over ten years.

Over the whole period, proportion of the target population who received a 3rd dose of in Europe and Northern America peaked at 84.0% in 2019 and was at its lowest, 39.0%, in 2008.

That places Europe and Northern America 9th out of 37 groups with data for 2024, putting it in the top quarter.

The long-run direction has been consistently rising across the 17 years of available data.

Proportion of the target population who received a 3rd dose of in Europe and Northern America, year by year

Annual values for Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%) in Europe and Northern America, 2008 to 2024.
Year Value Change
2008 39.0%
2009 43.0% +10.3%
2010 56.0% +30.2%
2011 58.0% +3.6%
2012 59.0% +1.7%
2013 60.0% +1.7%
2014 61.0% +1.7%
2015 61.0% +0.0%
2016 68.0% +11.5%
2017 76.0% +11.8%
2018 81.0% +6.6%
2019 84.0% +3.7%
2020 81.0% -3.6%
2021 82.0% +1.2%
2022 83.0% +1.2%
2023 83.0% +0.0%
2024 83.0% +0.0%

Biggest year-on-year movements

Years where Proportion of the target population who received a 3rd dose of in Europe and Northern America changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2010 +30.2% 43.0% 56.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 41.0% 39.0% 43.0% 2
2010s 66.4% 56.0% 84.0% 10
2020s 82.4% 81.0% 83.0% 5

Countries ranked near Europe and Northern America

  1. 7 Bhutan 98.0% compare
  2. 7 Guyana 98.0% compare
  3. 7 Portugal 98.0% compare
  4. 7 Rwanda 98.0% compare
  5. 11 Bangladesh 97.0% compare
  6. 11 Luxembourg 97.0% compare
  7. 11 Republic of Korea 97.0% compare
  8. 11 Tunisia 97.0% compare
  9. 11 Korea 97.0% compare

See the full ranking of 194 places →

More infrastructure data for Europe and Northern America

All data for Europe and Northern America →

Frequently asked questions

What is proportion of the target population who received a 3rd dose of in Europe and Northern America?
Proportion of the target population who received a 3rd dose of in Europe and Northern America was 83.0% in 2024, according to United Nations Statistics Division, SDG Global Database.
What is the highest proportion of the target population who received a 3rd dose of recorded in Europe and Northern America?
The highest recorded value was 84.0% in 2019.
What is the lowest proportion of the target population who received a 3rd dose of recorded in Europe and Northern America?
The lowest recorded value was 39.0% in 2008.
How does Europe and Northern America rank for proportion of the target population who received a 3rd dose of?
Europe and Northern America ranks 9th out of 37 groups with data for 2024.
Is proportion of the target population who received a 3rd dose of rising or falling in Europe and Northern America?
Over the last ten years it is up 36.1%. The long-run trend across the full record is rising.
Where does this Europe and Northern America data come from?
The figures come from United Nations Statistics Division, SDG Global Database, published as part of Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 17 observations, free to reuse under UN SDG Global Database (open, attribution requested).

Share, cite or embed this page

Cite this page

Proportion of the target population who received a 3rd dose of in Europe and Northern America. Statizoid, drawing on United Nations Statistics Division, SDG Global Database. Retrieved 13 September 2026, from https://infrastructure.statizoid.com/stat/proportion-of-the-target-population-who-received-a-3rd-dose-of-pneumococcal-conjugate/europe-and-northern-america/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under UN SDG Global Database (open, attribution requested); please keep the attribution.

<a href="https://infrastructure.statizoid.com/stat/proportion-of-the-target-population-who-received-a-3rd-dose-of-pneumococcal-conjugate/europe-and-northern-america/">Proportion of the target population who received a 3rd dose of in Europe and Northern America</a> — Statizoid

About this data

Indicator
Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)
Source
United Nations Statistics Division, SDG Global Database
Licence
UN SDG Global Database (open, attribution requested)
Coverage
194 places, 2,558 data points, 2008–2024
Last refreshed